Atlas Trials

VA-CAG Two-Week vs. Three-Week Regimen for Induction Remission in Newly Diagnosed Acute Myeloid Leukemia.

Clinical trial NCT07642453 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07642453
Sponsor
Hematology department of the 920th hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia (AML)
Start date
2026-06-01
Primary completion
2028-06-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.